Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Acadia Pharmaceuticals buy Robert W. Baird

Start price
€15.02
09.05.24 / 50%
Target price
€26.02
09.05.25
Performance (%)
5.19%
End price
€15.80
10.05.25
Summary
This prediction ended on 10.05.25 with a price of €15.80. With a performance of 5.19%, the BUY prediction by Robert_W__Baird for Acadia Pharmaceuticals closed with a slight gain. Robert_W__Baird has a follow-up prediction for Acadia Pharmaceuticals where he still thinks Acadia Pharmaceuticals is a Buy. Robert_W__Baird has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Acadia Pharmaceuticals -1.090% -1.090% 36.563%
iShares Core DAX® -0.793% 4.201% 19.951%
iShares Nasdaq 100 -2.376% 0.857% 4.704%
iShares Nikkei 225® -2.701% -0.147% 12.609%
iShares S&P 500 -1.689% 1.244% 3.144%

Comments by Robert_W__Baird for this prediction

In the thread Acadia Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 5.19%
Target price 26.020
Change
Ends at 09.05.25

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Robert W. Baird from $31.00 to $28.00. They now have an "outperform" rating on the stock.
Ratings data for ACAD provided by MarketBeat

In the thread Trading Acadia Pharmaceuticals
Prediction Buy
Perf. (%) 5.19%
Target price 26.020
Change
Ends at 09.05.25

Die von Robert_W__Baird gewählte maximale Laufzeit wurde überschritten

Current prediction by Robert_W__Baird for Acadia Pharmaceuticals

buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€19.56
19.05.25
€27.74
19.05.26
16.00%
18.12.25